MedTrace Logo

Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer

NCT02519972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1102

Last updated 2015-08-11

No results posted yet for this study

Summary

Screening with the use of low-dose computed tomography (LDCT) reduces mortality from lung cancer. Relatives with family history of lung cancer are at increased risk of lung cancer compared to those without a family history in pooled analysis. A prospective trial using LDCT of lung to screen the relatives with family history of lung cancer is needed.

Conditions

Interventions

DEVICE

low dose computed tomography

Participants will receive 3 round of low dose computed tomography screening every year

Sponsors & Collaborators

  • Ministry of Health and Welfare, Taiwan

    collaborator OTHER_GOV

  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Gee-Chen Chang, MD, PhD · Taichung Veterans General Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2011-03-31
Completion
2011-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02519972 on ClinicalTrials.gov